Skip to content

Ultra-sound Assisted Management of Heart Failure

Hand Carried Ultra-Sound Assisted Medical Management of Acute Decompensated Heart Failure. A Randomized Controlled Trial (USA-HF)

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04376424
Acronym
USA-HF
Enrollment
0
Registered
2020-05-06
Start date
2021-11-30
Completion date
2021-11-17
Last updated
2021-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Brief summary

The purpose of this study is to evaluate the impact of using hand carried ultrasound measurements of volume status in directing treatment of heart failure patients admitted with acute exacerbation.

Detailed description

The purpose of this study is to evaluate the impact of using hand carried ultrasound measurements of volume status in directing treatment of heart failure patients admitted with acute exacerbation. The use of hand carried ultrasound is expected to reduce hospital Length of stay, heart failure re-admission rates, emergency room visits and in hospital complications such as renal failure. The hypothesis tested is as follows: Null: The use of hand carried ultrasound in the management of heart failure patients did not change outcome. Alternative: The use of hand carried ultrasound in the management of heart failure patients did change outcome. The study endpoints are as follows: 1. A primary endpoint will be the impact of using hand carried ultrasound on length of hospital stay. 2. The secondary endpoint will be 30 days re-admission following heart failure hospitalization, emergency room visits and in hospital complications such as renal failure. This is a randomized controlled un-blinded study that poses very minimal risk because patients will only undergo an ultrasound measurement of Inferior vein cava (IVC) and internal jugular vein diameter and compressibility. Also, the society will benefit greatly with the prospect of reducing hospitalization and medical complications, optimizing healthcare delivery to heart failure patients, and reducing hospitalization cost. The results of this study/study procedure will only direct medical therapy that heart failure patients usually receive through routine care such as dose and frequency of diuresis.

Interventions

DIAGNOSTIC_TESTHand Held Ultrasound

Guideline directed medical therapy for heart failure with the addition of hand held ultrasound

Sponsors

The University of Texas Medical Branch, Galveston
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. New admission from emergency department to heart failure ( red team) service for acute exacerbation of heart failure ( defined based on clinical and imaging characteristics , shortness of breath due to volume overload, CXR showing pulmonary vascular congestion/pulmonary edema, elevated NTproBNP, dyspnea Not secondary to infectious process (pneumonia). 2. Heart failure NYHA class III, IV 3. Age\>=18 years old

Exclusion criteria

1. End stage Renal disease on dialyses (ESRD on HD) or stage V CKD (defined as GFR\<15) 2. end stage Heart failure on chronic inotrope (example Milrinone) 3. Renal failure that deemed to be secondary to other reason (dehydration, renal or post renal (obstructive) 4. morbid obesity BMI \> 40 5. incarcerated patients (prison) TDC. 6. pregnant patients 7. Patients with dyspnea not mainly due to heart failure, ESRD patients, intubated patients 8. Aged less than 18 years.

Design outcomes

Primary

MeasureTime frameDescription
length of hospital stay (days)Immediately after dischargenumber of days from admission to discharge

Secondary

MeasureTime frameDescription
number of participant readmitted for any reason within 30 days of discharge, and percentage of participant ( out of all participant in each group) readmitted in each group within 30 days of discharge.One month after original dischargeassessment of readmission to hospital
percent change in GFROne month after original dischargeamount of change in GFR
Number of participants readmitted for heart failure with 30 days of discharge, and percentage of participant out of all participants in each group readmitted in each group within 30 daysOne month after dischargeFollow up telephone call after discharge
Time to readmissionassessed within 4 weeks from index admission (i.e. thirty days readmission)time between original hospitalization and readmission
Number of right heart catheterization in each group and percentage of right heart catheterization in each groupOne month after admissiondocument what procedures were done
hospitalization Costimmediately after discharge of hospitalizationhospitalization cost measured for all hospitalization stay from admission to discharge for each participant

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026